Controlled substances: xylazine.

Legislative status

1. Introduced
2. In Committee
3. Reported by Committee
4. Floor Vote Scheduled
5. Passed One Chamber
6. Passed Both Chambers
7. Sent to Executive
8. Signed into Law

Vote

Read third time. Passed. (Ayes 38. Noes 0. Page 1472.) Ordered to the Assembly. · Jun 3, 2025

Hearings

• Appropriations Committee Hearing
  Appropriations · Aug 29, 2025
• Appropriations Committee Hearing
  Appropriations · Jul 16, 2025
• Public Safety Committee Hearing
  Public Safety · Jul 1, 2025
• Appropriations Committee Hearing
  Appropriations · May 23, 2025
• Appropriations Committee Hearing
  Appropriations · Apr 7, 2025

History

1. Aug 29, 2025August 29 hearing: Held in committee and under submission.
2. Jul 16, 2025July 16 set for first hearing. Placed on APPR. suspense file.
3. Jul 2, 2025From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (July 1). Re-referred to Com. on APPR.
4. Jun 9, 2025Referred to Com. on PUB. S.
5. Jun 4, 2025In Assembly. Read first time. Held at Desk.
6. Jun 3, 2025Read third time. Passed. (Ayes 38. Noes 0. Page 1472.) Ordered to the Assembly.
7. May 23, 2025Read second time. Ordered to third reading.
8. May 23, 2025From committee: Do pass. (Ayes 6. Noes 0. Page 1187.) (May 23).
9. May 16, 2025Set for hearing May 23.
10. Apr 7, 2025April 7 hearing: Placed on APPR. suspense file.
11. Mar 28, 2025Set for hearing April 7.
12. Mar 25, 2025From committee: Do pass and re-refer to Com. on APPR. (Ayes 6. Noes 0. Page 532.) (March 25). Re-referred to Com. on APPR.

The 12 most recent of 16 recorded actions.

Sponsors

• Ashby · sponsor

Bill text

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Topics

Share